Further clinical correlation analysis indicated that high GDF6 expression was significantly associated with advanced pathological stages and poor prognosis in endometrial cancer (UCEC) and gastric adenocarcinoma (STAD). The gene discussed is GDF6; the disease is gastric adenocarcinoma.